Deal Between Apple Inc. (AAPL) & Visa (V) Makes Sense: Jim Cramer:

On CNBC’s Mad Dash, Jim Cramer talked about what to watch out for on the market and even took a look at a potential partnership between iPhone-maker Apple Inc. (NASDAQ:AAPL) and credit card company Visa Inc (NYSE:V).

AAPL Apple Store

There have been talks about Apple Inc. (NASDAQ:AAPL) working on a deal with a number of payment-providers, including Visa Inc (NYSE:V) to integrate their services in its upcoming products, namely iPhone 6, which is expected to be launched either this month or the next one.

Mobile payment is a hot topic, and Cramer noted that one of the several things likely to make iPhone 6 an iconic device is the inclusion of the mobile payment in it. He said that a partnership between Apple Inc. (NASDAQ:AAPL) and Visa Inc (NYSE:V) cannot be far fetched because Visa CEO, Charles W. Scharf, alluded to something of that nature as the company’s most recent conference call.

However, Cramer also said that official public utterances of a possible deal between Apple and Visa Inc (NYSE:V) on mobile payment may not happen as yet because Apple Inc. (NASDAQ:AAPL) ordinarily requires its partners to keep silent on their dealings.

“In the Visa call, which I liked, Charles W. Scharf talked about the revolution is coming in mobile payment and they keep thinking what is the handset; who is going to embrace it?  This one says it is going to be Apple,” he said.

He went on to say that a mobile payment deal between Apple Inc. (NASDAQ:AAPL) and Visa Inc (NYSE:V) has all the ingredients of being a “game-changer.” He cited the amazing products from the companies and how they rate among consumers. In fact, at that point Cramer said Visa a fantastic relationship with many banks, which means its move to mobile payment has a lot of support.

“Mobile payment is the way of the future. That every single CEO I speak to on retail says ‘we have to get mobile payment.’ Recently I did have a group of retailers that are very much involved with mobile payment and are waiting for this solution of Visa. Don’t forget Visa has a fantastic relationship with also every bank,” concluded Cramer.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!